Home » Genzyme Biosurgery Shareholders Receive $64 Million Settlement
Genzyme Biosurgery Shareholders Receive $64 Million Settlement
Shareholders of Genzyme Biosurgery, the former tracking stock of the Genzyme Corporation, received their $64 million settlement from the Class Action lawsuit filed against Genzyme Corporation. …
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
07May
-
14May
-
30May